Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 4.3% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 247.2 million in 2016 and is expected to reach USD 305.12 million by 2021.Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique that provides prolonged cardiac and respiratory support to patients whose heart and lungs are inept to provide an adequate amount of gas exchange to sustain life.
- Advertising -
The technology for ECMO is largely a consequence of cardiopulmonary bypass, which provides shorter-term support. This intervention has mostly been used on children, but it is expecting to see more use in adults with cardiac and respiratory failure.
ECMO works by removing blood from the person's body and artificially removing the carbon dioxide and oxygenating red blood cells. Usually, it is used in either post-cardiopulmonary bypass or in late stage treatment of a person with a profound heart and/or lung failure.
- Advertising -
Full report at: www.marketdataforecast.com/market-…hine-market-4977/
The growth of the market can be attributed to the increase in cases of cardiovascular and respiratory diseases, the rise in the adoption of ECMO as a bridge to lung transplantation, rising number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the rise in the geriatric population and the number of people suffering from diseases in populous countries are factors that are expected to drive the market growth.
Moreover, increase in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are anticipated to further expand the COPD incidence rate. Identified risk factors, such as the rise in the tobacco consumption trend in both, males and females, are further aiding the market growth.
However, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.
The global Extracorporeal Membrane Oxygenation Machine Market Segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV).
The veno-venous (VV) segment is expected to account for the largest share of this market segment. The large share of this segment is primarily due to the high incidences of respiratory failure, rise in lung transplants, and technological advancements.
The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR).
The respiratory segment accounts for the largest share of this market segment. The large share of this segment can be credited to factors such as rise in the incidence of respiratory failure, lung cancer, and lung transplants, and increasing adoption of ECMO.
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Middle East and Africa. North America accounts for the largest share of the market.
The Asia-Pacific market is expected to grow at the highest CAGR and aid the revenue pocket for companies offering ECMO systems.
Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: